ENDOCRINOLOGY
Early diagnosis of PCOS can be challenging due to the wide range of presenting symptoms.
appropriate management plans and guidance.
As well as giving patients direction
through a diagnosis, using a blood test to diagnose PCOS also promises system- wide benefits for the NHS, by keeping patients in the care pathway and allowing clinicians to make timely interventions for the management of PCOS.
Exposing gaps in women’s health guidance With the updated Rotterdam Criteria, it is now important that clinicians across the NHS can access the option of AMH testing for all patients, regardless of where they live. Because there is no dedicated NICE guidance on PCOS diagnosis, it is all the more important for the international guidelines to be shared more widely so that we can provide the clinical support that these women need consistently across the NHS. The Women’s Health Strategy for England in 2022 promised to develop specific NICE guidelines for PCOS – a clear recognition that government bodies understood the urgency of greater consistency of care for patients, clearer pathways for clinicians, and more efficient use of NHS resources.2
The sad truth is that patients who
suffer with PCOS, and clinicians who treat it, are frustrated. Little work has been done to reach a cure for PCOS, with progress hampered by lack of research, investigation, and resources. Women with long-term conditions such as PCOS are often left feeling abandoned and alone. Our healthcare system could do so much more to recognise – and therefore mitigate – their suffering. However, it is heartening that we have advanced a collective understanding of the importance of prevention and earlier diagnosis of PCOS. The introduction of a blood test as a diagnostic option means that, if our system can employ it correctly, patients will no longer have to wait years to be diagnosed. But like all innovations, it is only of benefit if it actually reaches those who need it -- and that’s where we have a great deal more work to do.
References 1
https://www.monash.edu/__data/assets/
pdf_file/0003/3379521/Evidence-Based- Guidelines-2023.pdf
2
https://www.gov.uk/government/ publications/womens-health-strategy- for-england/womens-health-strategy-for- england
Acknowledgement n This article first appeared in
The Clinical Services Journal (CSJ. 2024 Nov; 23[10]:61-3) and is reproduced here by kind permission.
Dr Anne Connolly MBE is the chair of the Primary Care Women’s Health Forum (PCWHF), and RCGP Clinical Champion For Women’s Health (Retired). After a two-year
volunteer posting to an under-resourced mission hospital in rural Zimbabwe Anne returned to General Practice in inner-city Bradford in 1990 and, until recently, was working as a GP providing care for asylum seekers, refugees, homeless and sex workers.
She was a GPwSI in gynaecology ,
accredited as a hysteroscopist and FSRH trainer. She has been involved with commissioning since 2006 and retired as a CCG clinical board member with remit for maternity, women’s, children and young people’s healthcare in 2019. Anne was the co-editor of Women’s Health in Primary Care and was also honoured to be awarded an MBE for her work in women’s health in the 2021 Queen’s Birthday Honours List.
WWW.PATHOLOGYINPRACTICE.COM JUNE 2025
43
AdobeStock / freshidea
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
